nicotinamide mononucleotide has been researched along with Breast Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bae, MG; Baur, JA; Brogren, D; Cho, CH; Choi, J; Corujo-Ramirez, A; Hawse, JR; Hou, X; Jang, MH; Kirkeby, LA; Oliveros, A; Rashid, MA; Tang, JJ; Weroha, SJ; Yoo, KH | 1 |
1 other study(ies) available for nicotinamide mononucleotide and Breast Neoplasms
| Article | Year |
|---|---|
Nicotinamide Mononucleotide Prevents Cisplatin-Induced Cognitive Impairments.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Proliferation; Cisplatin; Cognitive Dysfunction; Female; Humans; Mice; Mice, SCID; Neuroprotective Agents; Nicotinamide Mononucleotide; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2021 |